CSMD1
protein-codingCUB and Sushi multiple domains 1, the group of Protein phosphatase 1 regulatory subunits|Complement system regulators and receptors|Sushi domain containing
Gene summary
Predicted to act upstream of or within several processes, including learning or memory; mammary gland branching involved in pregnancy; and reproductive structure development. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~2,059.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0100038
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0005258
Submitter: Ambry Genetics
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CSMD1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_033225.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 85 | 40 | 130 | ||
| missense | 1 | 818 | 28 | 11 | 858 | |
| nonsense | 1 | 7 | 8 | |||
| start loss | 0 | |||||
| frameshift | 3 | 3 | ||||
| splice donor/acceptor (+/-2bp) | 10 | 10 | ||||
| Total | 1 | 1 | 843 | 113 | 51 | 1009 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_150094.5 | 70 | MANE Select | |
| Ensembl | ENSP00000489225.1 | 70 | MANE Select | |
| Ensembl | ENSP00000334828.6 | 56 | Standard | |
| Ensembl | ENSP00000383047.3 | 68 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- startle response
- glucose homeostasis
Cellular Component
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000537824
- Coding exons
- 70
- Length
- 2059620
- Individuals with no LoFs
- 125645
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 51
- Defined
- 125696
- p
- 0.000203
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -6.87 | 2787 | 1.94e+3 | 1.44 | 0.000112 | 23041 |
| Missense (PolyPhen) | 1120 | 959.08 | 1.1678 | 11311 | ||
| Synonymous | -16.5 | 1395 | 801 | 1.74 | 0.0000557 | 6770 |
| Loss of Function | 10.4 | 27 | 177 | 0.153 | 0.00000922 | 2109 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00056 | 0.00049 | rare |
| Latino/Admixed American | 0.00023 | 0.00023 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.000049 | 0.000046 | rare |
| European (Non-Finnish) | 0.00020 | 0.00018 | rare |
| South Asian | 0.00030 | 0.00026 | rare |
| Other | 0.00018 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Potential suppressor of squamous cell carcinomas.;
Recessive Scores
- pRec
- 0.124
Intolerance Scores
- RVIS EVS
- -7.11
- RVIS percentile EVS
- 0.02
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.746
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |